📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Angion Biomedica

1.1 - Company Overview

Angion Biomedica Logo

Angion Biomedica

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage organ restoration biopharmaceuticals focused on renal disease.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Angion Biomedica

A1M Pharma Logo

A1M Pharma

HQ: Sweden Website
  • Description: Provider of alpha 1 microglobulin, a body protein that is of major importance for the body's defense against oxidative stress.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full A1M Pharma company profile →
Judo Bio Logo

Judo Bio

HQ: United States Website
  • Description: Provider of precision therapeutics targeting specific cell populations to address genetic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Judo Bio company profile →
Diality Logo

Diality

HQ: United States Website
  • Description: Provider of the Moda-flx Hemodialysis System, a portable hemodialysis machine for home use that enables patients with kidney disease to self-treat; a medical device company developing solutions that improve lives impacted by kidney disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Diality company profile →
Iviva Medical Logo

Iviva Medical

HQ: United States Website
  • Description: Provider of bioartificial kidney solutions for end-stage kidney disease, including fully implantable bioartificial kidneys; proprietary 3D-printed scaffold construction for human-scale solute-exchange grafts; Thin Film Interposition scaffolding; biologic blood purification with a cellular membrane-based device; and autologous renal grafts from patient-derived cells potentially eliminating the need for immunosuppression.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iviva Medical company profile →
CreatiVasc Logo

CreatiVasc

HQ: United States Website
  • Description: Provider of innovative, easy-to-use vascular technologies and medical devices for the treatment of end-stage renal disease, addressing universal problems of vascular access for dialysis patients to improve survivability and quality of life; founded in 2004.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CreatiVasc company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Angion Biomedica

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Angion Biomedica

2.2 - Growth funds investing in similar companies to Angion Biomedica

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Angion Biomedica

4.2 - Public trading comparable groups for Angion Biomedica

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Angion Biomedica

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Angion Biomedica

What does Angion Biomedica do?

Angion Biomedica is a provider of clinical-stage organ restoration biopharmaceuticals focused on renal disease.

Who are Angion Biomedica's competitors?

Angion Biomedica's competitors and similar companies include A1M Pharma, Judo Bio, Diality, Iviva Medical, and CreatiVasc.

Where is Angion Biomedica headquartered?

Angion Biomedica is headquartered in United States.

How many employees does Angion Biomedica have?

Angion Biomedica has 1,000 employees 🔒.

When was Angion Biomedica founded?

Angion Biomedica was founded in 2010 🔒.

What sector and industry vertical is Angion Biomedica in?

Angion Biomedica is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Angion Biomedica

Who are the top strategic acquirers in Angion Biomedica's sector and industry

Top strategic M&A buyers and acquirers in Angion Biomedica's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Angion Biomedica?

Top strategic M&A buyers groups and sectors for Angion Biomedica include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Angion Biomedica's sector and industry vertical

Which are the top PE firms investing in Angion Biomedica's sector and industry vertical?

Top PE firms investing in Angion Biomedica's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Angion Biomedica's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Angion Biomedica's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Angion Biomedica's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Angion Biomedica include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Angion Biomedica's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Angion Biomedica?

The key public trading comparables and valuation benchmarks for Angion Biomedica include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Angion Biomedica for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Angion Biomedica with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Angion Biomedica's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Angion Biomedica with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Angion Biomedica's' sector and industry vertical?

Access recent funding rounds and capital raises in Angion Biomedica's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Angion Biomedica